Search details
1.
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.
Sci Rep
; 13(1): 11065, 2023 07 08.
Article
in English
| MEDLINE | ID: mdl-37422576
2.
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
JTO Clin Res Rep
; 4(12): 100602, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38124790
3.
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Cancers (Basel)
; 15(15)2023 Jul 28.
Article
in English
| MEDLINE | ID: mdl-37568646
Results
1 -
3
de 3
1
Next >
>>